Fair Value Measures (Narrative) (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended	6 Months Ended
Apr. 30, 2012	Apr. 30, 2012
Fair Value Measures [Abstract]
Reduction in research and development expenses	$ 0.7	$ 3.0
Contingent consideration	1.4	1.4
Non-marketable equity securities, carrying value	$ 4.4	$ 4.4

Aggregate carrying value of owned private equity or other securities for which a quoted market price is not readily determinable, the value of which has been determined by management based upon fair value methods, including pricing of similar securities and valuation techniques and is included in the schedule of financial condition or the balance sheet.

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Audit and Accounting Guide (AAG)

-Number AAG-BRD

-Chapter 7

-Paragraph 6-14

-IssueDate 2006-05-01

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Rule 15c3

-Number 240

-Section 3

-Paragraph i

-Article 15c3

Name:	us-gaap_SecuritiesOwnedNotReadilyMarketable
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant